文献速递肝胆胰外科围术期管理与 ERAS

胰腺切除术联合静脉切除前预测病理性静脉侵犯:影像学何时能反映真实情况?

Predicting pathologic venous invasion before pancreatectomy with venous resection: When does radiology tell the truth?
PubMed 文献 · Surgery · 2022-01-21

该研究在198例因胰腺腺癌行胰腺切除术联合静脉切除的患者中,评估了6种影像学分类方法对病理性静脉侵犯的预测价值,并分析了临床与生物学因素。病理性静脉侵犯见于124例(63.2%)。多变量分析显示Lu分类、血清CA19-9升高和术前新辅助化疗是与病理性静脉侵犯独立相关的因素。肿瘤-静脉周径接触>50%和/或静脉壁变形与更高的病理性静脉侵犯率(80% vs 52%)、更深的静脉侵犯、R1切除、更高输血率和动脉切除率相关。

要点

  • 肿瘤-静脉周径接触>50%和/或静脉壁变形与病理性静脉侵犯率高达80%相关。
  • Lu分类、CA19-9升高和术前新辅助化疗是病理性静脉侵犯的独立相关因素。
  • 影像学特征联合生物学和临床因素可能更好地细化术前静脉切除的需求。

核心结论

  • 术前影像学检测到肿瘤-静脉周径接触>50%和/或静脉壁变形与高达80%的病理性静脉侵犯病例相关。
  • 影像学特征联合生物学(CA19-9)和临床(术前化疗)因素可能更好地细化术前静脉切除的需求。

研究设计与样本

  • 研究为队列研究,纳入198例因胰腺腺癌行胰腺切除术联合静脉切除的患者(160例胰十二指肠切除术和38例全胰腺切除术)。
  • 测试了6种影像学分类方法(Nakao、Ishikawa、MD Anderson、Lu、Raptopoulos和National Comprehensive Cancer Network方法)对病理性静脉侵犯的预测价值,并通过多变量logistic分析识别决定病理性静脉侵犯的影像学和临床因素。

主要发现

  • 病理性静脉侵犯见于124例患者(63.2%)。
  • 多变量logistic回归分析识别Lu分类(比值比=1.77,95%置信区间=1.34-2.35;P<.0001)、血清CA19-9升高(比值比=1.97,95%置信区间=1.00-3.90;P=.04)和术前新辅助化疗(比值比=0.38,95%置信区间=0.18-0.79;P=.009)为与病理性静脉侵犯独立相关的因素。
  • 影像学肿瘤-血管接触大于周径50%或静脉壁变形与显著更高的病理性静脉侵犯率(80% vs 52%;P<.0001)、更深的(中膜-内膜)静脉侵犯(47% vs 25%;P<.0001)、R1切除(58% vs 41%;P=.03)、更高的输血率(84% vs 66%;P=.005)和动脉切除率(43% vs 27%;P<.0001)相关。
  • 无论是否使用新辅助化疗或CA19-9在术前治疗下是否正常化,肿瘤-静脉周径接触>50%和/或静脉壁变形仍与显著更高的病理性静脉侵犯率相关。

关键数值与推荐

  • 病理性静脉侵犯定义为病理学检测到的静脉侵犯,见于124/198例(63.2%)。
  • 肿瘤-静脉周径接触>50%和/或静脉壁变形与病理性静脉侵犯率80% vs 52%(P<.0001)相关。
  • 肿瘤-静脉周径接触>50%和/或静脉壁变形与中膜-内膜静脉侵犯率47% vs 25%(P<.0001)相关。
  • 肿瘤-静脉周径接触>50%和/或静脉壁变形与R1切除率58% vs 41%(P=.03)相关。
  • 肿瘤-静脉周径接触>50%和/或静脉壁变形与输血率84% vs 66%(P=.005)和动脉切除率43% vs 27%(P<.0001)相关。

临床怎么用

  • 术前影像学检测肿瘤-静脉周径接触>50%和/或静脉壁变形可用于识别病理性静脉侵犯高风险患者。
  • 结合影像学特征、血清CA19-9水平和术前新辅助化疗史可能更好地细化术前静脉切除的需求。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients factors in addition to radiological characteristics could predict the presence of pathologic venous invasion in patients undergoing pancreatectomy with venous resection. METHODS: We tested the predictive value of 6 radiological classification methods for predicting pathologic venous invasion-the Nakao, Ishikawa, MD Anderson, Lu, Raptopoulos, and National Comprehensive Cancer Network methods-on a cohort of 198 pancreatectomies (160 pancreaticoduodenectomies and 38 total pancreatectomies) with venous resection for pancreatic adenocarcinomas. Radiological and clinical factors determining pathologic venous invasion were identified by multivariable logistic analysis. RESULTS: Pathologic venous invasion was detected in 124 patients (63.2%). The multivariable logistic regression analysis identified Lu classification (odds ratio = 1.77, 95% confidence interval =1.34-2.35; P < .0001), elevated serum CA19-9 values (odds ratio = 1.97, 95% confidence interval = 1.00-3.90; P = .04), and preoperative neoadjuvant chemotherapy (odds ratio = 0.38, 95% confidence interval = 0.18-0.79; P = .009) as independent factors associated with pathologic venous invasion. Radiological tumor-vessel contact greater than 50% of the circumference or venous wall deformity was associated with a significantly higher rate of pathological venous invasion (80% vs 52%; P < .0001), deeper (media-intima) venous invasion (47% vs 25%; P < .0001), R1 resection (58% vs 41%; P = .03), higher transfusions (84% vs 66%; P = .005), and arterial resection rates (43% vs 27%; P < .0001). Tumor-vein circumference contact of >50% and/or venous wall deformity was still associated with significantly higher rates of pathologic venous invasion, regardless of whether neoadjuvant chemotherapy was used or not and CA19-9 normalized or not under preoperative treatment. CONCLUSION: Preoperative radiological detection of tumor-vein circumference contact >50% and/or venous wall deformity is associated with up to 80% of cases of pathological venous invasion. The combination of radiologic features with biological (CA19-9) and clinical (presence of preoperative chemotherapy) factors could better refine preoperatively the need for venous resection.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Addeo P, Charton J, de Marini P, et al. Predicting pathologic venous invasion before pancreatectomy with venous resection: When does radiology tell the truth? Surgery. 2022. PMID: 35074172. doi:10.1016/j.surg.2021.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。